Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
    • Patient Resources
    • Eddie’s Story
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

    Education, Rare Cancer

    Rare Cranial Synovial Sarcoma Case Highlights Importance of Accurate Diagnosis

    May 11, 2026 ayushis Comments Off on Rare Cranial Synovial Sarcoma Case Highlights Importance of Accurate Diagnosis
    Two doctors examine X-ray images of a human skull, one in profile and one facing forward, while discussing the results in a well-lit medical setting.

    Synovial sarcoma is a rare and aggressive soft tissue cancer that most often develops near the joints of the arms or legs. In very rare cases, however, it can appear in unusual locations — including the skull and brain region.

    A newly published case report describes a patient diagnosed with primary cranial synovial sarcoma who later developed multiple bone lesions that initially raised concern for metastatic disease. The case highlights how advanced pathology and molecular testing can play a critical role in reaching the correct diagnosis.

    A Rare Form of Synovial Sarcoma

    Primary cranial synovial sarcoma is extremely uncommon. In this case, a woman presented with a swelling in the left parietal region of the skull. Imaging revealed an extradural mass, which was surgically removed with wide margins.

    Pathology testing confirmed a high-grade synovial sarcoma, including the presence of the SS18 gene rearrangement, one of the defining molecular features of synovial sarcoma.

    After surgery, the patient received radiation therapy and remained disease-free for approximately two years.

    New Bone Lesions Raise Concern

    Two years later, the patient developed progressive elbow pain. Scans revealed multiple lytic bone lesions involving the arm, pelvis, sacrum, and femur. PET imaging showed increased metabolic activity consistent with malignancy.

    At first, physicians were concerned these lesions represented metastatic synovial sarcoma.

    However, biopsies from two separate bone sites revealed something unexpected.

    The Importance of Molecular Testing

    Further pathology testing showed the bone lesions were actually consistent with solitary fibrous tumor (SFT) — a different type of rare soft tissue tumor.

    Key findings included:

    • Diffuse STAT6 positivity
    • Absence of SS18 rearrangement

    These molecular and immunohistochemical results helped doctors determine that the lesions were not metastatic synovial sarcoma, but instead represented a second primary tumor.

    The diagnosis was confirmed through multiple pathology reviews and multidisciplinary tumor board evaluation.

    Why This Case Matters

    This rare case highlights several important lessons for the synovial sarcoma community:

    • Synovial sarcoma can appear in rare locations, including the skull
    • New lesions are not always metastatic disease
    • Molecular testing is critical for accurate diagnosis
    • Multidisciplinary sarcoma care helps guide complex treatment decisions

    The case also reinforces the growing importance of combining imaging, pathology, and molecular profiling when evaluating rare cancers.

    For more detailed information, please refer to the original publication. For more information about synovial sarcoma resources and support, please visit our website.

    ayushis

    Post navigation

    Previous
    Next

    Search

    Categories

    • Black Flag Racing (2)
    • Case Study (3)
    • Children (1)
    • CHOP (3)
    • Development (10)
    • Dr. Theodore Laetsch (3)
    • Education (19)
    • Europe Expansion (1)
    • Healthcare (9)
    • Latest News (13)
    • Programs (1)
    • Rare Cancer (7)
    • Rare Cancer Funding (2)
    • Research (19)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (4)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • A group photo collage introduces the Medical Advisory Board for the Synovial Sarcoma Foundation, featuring 11 professionals in business or medical attire, with the foundation's logo and branding text on a colorful background.
      Synovial Sarcoma Foundation Announces Formation of Medical Advisory Board
    • A scientist wearing safety glasses and gloves closely examines samples through a microscope in a laboratory setting, concentrating on her research.
      Breaking Down Synovial Sarcoma’s Defenses: A study on Immune Evasion and Targeted Treatment
    • A scientist wearing a lab coat, gloves, safety goggles, and a mask examines a test tube beside a microscope in a laboratory. Another scientist works in the background. Scientific equipment and screens are visible.
      When Synovial Sarcoma Hides in Plain Sight: A Diagnostic Wake-Up Call

    Tags

    Afami-cel Cancer Research cancer survivorship CHOP FDA approved cancer therapy immunotherapy localized synovial sarcoma MAGE-A4 synovial sarcoma NY-ESO-1 synovial sarcoma patient-centered care precision medicine radiation therapy for synovial sarcoma Rare Cancer Rare Cancer Europe rare cancer research rare disease rare soft tissue sarcoma research sarcoma imaging sarcoma patient experience sarcoma research sarcoma surveillance sarcoma treatment soft tissue sarcoma solitary fibrous tumor SPAGN Synovial Sarcoma synovial sarcoma chemotherapy synovial sarcoma diagnosis Synovial Sarcoma Europe synovial sarcoma follow-up Synovial Sarcoma Foundation Synovial Sarcoma Italy synovial sarcoma market synovial sarcoma outcomes synovial sarcoma recurrence synovial sarcoma surgery synovial sarcoma survival synovial sarcoma treatment T-Cell Therapy targeted therapy T Cell TECELRA tumor size synovial sarcoma webinar

    Related posts

    A group photo collage introduces the Medical Advisory Board for the Synovial Sarcoma Foundation, featuring 11 professionals in business or medical attire, with the foundation's logo and branding text on a colorful background.
    Latest News

    Synovial Sarcoma Foundation Announces Formation of Medical Advisory Board

    June 22, 2026 ayushis Comments Off on Synovial Sarcoma Foundation Announces Formation of Medical Advisory Board

    11 Leading Oncologists and Researchers Unite to Accelerate Progress for Synovial Sarcoma Patients PHILADELPHIA [June 22, 2026] The Synovial Sarcoma Foundation (SSF) today announced the formation of its Medical Advisory Board, bringing together 11 internationally recognized clinicians and researchers to serve as the central coordinating body for synovial sarcoma research, treatment, and advocacy. The board […]

    A doctor wearing a white coat and stethoscope holds a glowing light bulb in one hand, symbolizing innovation or new ideas in healthcare.
    Development, Case Study

    Rare Synovial Sarcoma Cases Highlight New Limb-Sparing Reconstruction Approach

    May 29, 2026 ayushis Comments Off on Rare Synovial Sarcoma Cases Highlight New Limb-Sparing Reconstruction Approach

    A new case report published in the World Journal of Surgical Oncology explored an innovative reconstruction technique for rare soft tissue sarcomas of the hand and foot, including synovial sarcoma. The study was authored by Naoya Terao, Naoki Oike, Takashi Ariizumi, and colleagues, with research conducted primarily through the Division of Orthopedic Surgery at Niigata […]

    A healthcare professional in blue scrubs holds the hand of a patient in bed, offering comfort and support in a bright, sunlit room.
    Research, Rare Cancer

    Research Highlights Importance of Patient-Centered Sarcoma Surveillance

    May 22, 2026 ayushis Comments Off on Research Highlights Importance of Patient-Centered Sarcoma Surveillance

    A 2022 study explored how sarcoma patients feel about long-term surveillance imaging after treatment, highlighting the emotional, financial, and practical challenges that can come with ongoing follow-up care. The study, led by Sarah C. Tepper, Anna K. Holten, Cara A. Cipriano, and colleagues evaluated patient concerns surrounding surveillance imaging through the “Sarcoma Surveillance Survey.” The […]

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    1025 Thomas Jefferson St. NW, Suite W-3200, Washington DC 20007
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch